The most important product is eribulin (Halaven), a fully synthetic macrocyclic ketone analogue of the marine sponge natural product halichondrin B. Aricept, another antitumor compound of Eisai, lost patent protection last year and shows reduction in sales.

Eisai press release, May 13, 2013